EP2291380
Nalmefenforlyf.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
23.4.2009EP published:
7.9.2011EP application number:
09733923.8
EP translation filed:
7.12.2011Grant published:
15.1.2012EPO information:
European Patent Register
Max expiry date:
22.4.2029Expiry date:
22.4.2023
Title:
NALMEFENE PRODRUGS
Timeline
Today
23.4.2009EP application
7.9.2011EP Publication
7.12.2011Translation submitted
15.1.2012Registration published
22.4.2023Expires
Owner
Name:
Janssen Pharmaceutica N.V.Address:
Turnhoutseweg 30, 2340, Beerse, BE
Inventor
Name:
GUILLAUME, Michel, Joseph, Maurice, AndréAddress:
Beerse, BE
Name:
GAEKENS, TimAddress:
Beerse, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
08155094Date:
24.4.2008Country:
EP
Classification
Categories:
C07D 489/08, A61K 31/485, A61P 25/30
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 6.3.2012
Expires: 22.4.2013
Payer: Sigurjónsson & Thor ehf.
Number: 5
Paid: 5.3.2013
Expires: 22.4.2014
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 6.3.2014
Expires: 22.4.2015
Payer: Árnason Faktor
Number: 7
Paid: 9.3.2015
Expires: 22.4.2016
Payer: Árnason Faktor
Number: 8
Paid: 11.3.2016
Expires: 22.4.2017
Payer: Árnason Faktor
Number: 9
Paid: 7.3.2017
Expires: 22.4.2018
Payer: Árnason Faktor
Number: 10
Paid: 5.3.2018
Expires: 22.4.2019
Payer: Árnason Faktor
Number: 11
Paid: 8.3.2019
Expires: 22.4.2020
Payer: Árnason Faktor
Number: 12
Paid: 10.3.2020
Expires: 22.4.2021
Payer: Árnason Faktor ehf.
Number: 13
Paid: 10.3.2021
Expires: 22.4.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 10.3.2022
Expires: 22.4.2023
Payer: Árnason Faktor ehf.